Merck & Co | 8-K: Merck Announces First-Quarter 2024 Financial Results
Apr 25 06:44 ET
Merck & Co | DEFA14A: Others
Apr 11 16:16 ET
Merck & Co | DEF 14A: Definitive information statements
Apr 11 16:12 ET
Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Mar 19 16:36 ET
Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Mar 19 16:32 ET
Merck & Co | 8-K: Peter C. Wendell Gave Notice to Merck & Co., Inc. Of His Intention to Retire from the Board of Directors of the Company as of the Company’s 2024 Annual Meeting of Shareholders on May 28, 2024
Feb 20 16:20 ET
Merck & Co | 8-K: Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
Feb 1 06:41 ET
Merck & Co | 8-K: The Board of Directors of the Company Elected Dalton E. Smart III to Serve as Senior Vice President Finance – Global Controller of the Company
Nov 28, 2023 16:51 ET
Merck & Co | 8-K: Merck Announces Third-Quarter 2023 Financial Results
Oct 26, 2023 06:38 ET
Merck & Co | 8-K: Merck Announces Second-Quarter 2023 Financial Results
Aug 1, 2023 06:46 ET
Merck & Co | 8-K: Poll Results of Merck & Co Meeting
May 26, 2023 09:00 ET
Merck & Co | 8-K: Merck & Co closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.050% Notes due 2028
May 17, 2023 16:31 ET
Merck & Co | 8-K: Merck Announces First-Quarter 2023 Financial Results
Apr 27, 2023 06:43 ET
Merck & Co | DEFA14A: Others
Apr 3, 2023 16:10 ET
Merck & Co | DEF 14A: Definitive proxy statements
Apr 3, 2023 16:06 ET
Merck & Co | 8-K: Merck & Co Announces Fourth-Quarter and Full-Year 2022 Financial Results
Feb 2, 2023 06:42 ET
Merck & Co | 8-K: Merck Announces Third-Quarter 2022 Financial Results
Oct 27, 2022 06:38 ET
Merck & Co | 8-K: Current report
Jul 28, 2022 06:36 ET
Merck & Co | 8-K: Current report
May 26, 2022 16:06 ET
Merck & Co | 8-K: Current report
Apr 28, 2022 06:35 ET
No Data
No Data